Safety and efficacy of new potassium binders on hyperkalemia management in patients with heart failure: a systematic review and meta-analysis of randomized controlled trials.
Pedro Emanuel de Paula CarvalhoThiago M A VeigaHenrique LacerdaMatheus R TofanelliDouglas M GewehrMaria C P NunesAna Cristina Dos Santos LopesPublished in: Clinical research in cardiology : official journal of the German Cardiac Society (2023)
The use of new potassium binders Patiromer or SZC in patients with HF at risk for hyperkalemia increased the rates of medical therapy optimization with renin-angiotensin-aldosterone inhibitors and reduced the incidence of hyperkalemia, at the cost of an increased prevalence of hypokalemia.